NO952485L - Antiinflammatorisk difluorpentapeptidderivat - Google Patents

Antiinflammatorisk difluorpentapeptidderivat

Info

Publication number
NO952485L
NO952485L NO952485A NO952485A NO952485L NO 952485 L NO952485 L NO 952485L NO 952485 A NO952485 A NO 952485A NO 952485 A NO952485 A NO 952485A NO 952485 L NO952485 L NO 952485L
Authority
NO
Norway
Prior art keywords
carbon atoms
covalent bond
integer
hydrophobic group
inflammatory
Prior art date
Application number
NO952485A
Other languages
English (en)
Other versions
NO952485D0 (no
Inventor
John Mcmillan Mciver
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO952485D0 publication Critical patent/NO952485D0/no
Publication of NO952485L publication Critical patent/NO952485L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Det beskrives anti-inflammatoriske forbindelser med struktur (I), R1 R2 R3 X-(CH2)rt-V-Z-CH-C(0)-NH-Cr+~C(0)-NH~CH (D R5 R< C=0 YO-C(0)-CH-NH-C(0)-CH-NH-C(0)-CF2 hvor : (a) -X er cyklisk alkyl med fra 4 til 15 karbon- atomer; forgrenet alkyl som har fra 6 til 15 karbonatomer; eller aryl med fra 6 til 15 karbon- atomer; (b) n er et helt tall fra O til 2; (c) -V- er -OC(0)-, -N(Q)C(0)-, -N(Q)C(S)-, -C(0)-, -S02- eller -P(0)(OH)-; (d) -Q er hydrogen; eller rett eller forgrenet kjede alkyl, mettet eller umettet med 1 eller 2 dobbeltbindinger, hvilket alkyl har fra 1 til 6 karbonatomer; eller -Q og -X er kovalent bundet og danner en cyklisk gruppe som innbefatter nitrogenet til hvilket -Q er bundet og fra 5 til 20 karbonatomer; (e) Z er -O- eller -NH-; når V er -OC(0)-, er -Z- -NH-; (f) -R1 er en hydrofob gruppe; (g) -R2 er en hydrofob gruppe; (h) -R3 er -(CH2)m-A-NH2 eller -(CH2)m-A-B-C(NH2)=NH hvor m er et helt tall fra 1 til omkring 6, -A- er en kovalent binding eller p-fenyl eller p-cyklohek- syl, og -B- er en kovalent binding eller -NH-; (i) -R4 er en hydrofob gruppe; (j) -R5 er -(CH2)ra-A-NH2 eller -(CH2)m-A-B-C(NH2)=NH hvor m er et helt tall fra 1 til omkring 6, -A- er en kovalent binding eller p-fenyl eller p-cykloheksyl, og -B- er en kovalent binding eller -NH-; og (k) -Y er hydrogen eller metyl. Det beskrives også farmasøytiske pre- parater omfattende ovenfor nevnte forbindelser og fremgangsmåter for å behandle inflammasjon eller smerte idet man anvender slike forbindelser og preparater.
NO952485A 1992-12-22 1995-06-21 Antiinflammatorisk difluorpentapeptidderivat NO952485L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99521792A 1992-12-22 1992-12-22
PCT/US1993/012349 WO1994014842A1 (en) 1992-12-22 1993-12-16 Difluoro-pentapeptide derivative anti-inflammatory agents

Publications (2)

Publication Number Publication Date
NO952485D0 NO952485D0 (no) 1995-06-21
NO952485L true NO952485L (no) 1995-08-22

Family

ID=25541529

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952485A NO952485L (no) 1992-12-22 1995-06-21 Antiinflammatorisk difluorpentapeptidderivat

Country Status (22)

Country Link
US (1) US5760002A (no)
EP (1) EP0675901A1 (no)
JP (1) JPH08505143A (no)
KR (1) KR950704350A (no)
CN (1) CN1056615C (no)
AU (1) AU697299B2 (no)
BR (1) BR9307728A (no)
CA (1) CA2152267C (no)
CZ (1) CZ286126B6 (no)
FI (1) FI953106A (no)
HU (1) HUT72977A (no)
IL (1) IL108031A0 (no)
MX (1) MX9400072A (no)
NO (1) NO952485L (no)
NZ (1) NZ259274A (no)
PE (1) PE5195A1 (no)
PL (1) PL177914B1 (no)
RU (1) RU2141971C1 (no)
SG (1) SG54306A1 (no)
SK (1) SK82795A3 (no)
TW (1) TW402607B (no)
WO (1) WO1994014842A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003002845A (ja) * 2001-04-03 2003-01-08 Univ Nihon 哺乳類の硬組織治療用組成物及びその治療方法
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
CA2789097C (en) 2005-04-28 2017-02-21 Proteus Digital Health, Inc. Pharma-informatics system
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
NZ596876A (en) 2009-05-06 2014-01-31 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009010B1 (en) * 1978-07-18 1983-03-02 Kabi AB Bradykinin inhibiting tripeptide derivatives, process for their preparation and pharmaceutical preparations containing them
HU177098B (en) * 1979-01-04 1981-07-28 Gyogyszerkutato Intezet Process for producing new peptidyl-n-carboxy-l-arginin-a
JPS5754157A (en) * 1980-09-19 1982-03-31 Nippon Kayaku Co Ltd L-argininal derivative and its preparation
HU184368B (en) * 1981-01-13 1984-08-28 Gyogyszerkutato Intezet Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate
JPS5830300B2 (ja) * 1981-11-02 1983-06-28 三菱化学株式会社 トリペプチドおよびその誘導体の製造法
JPS58164563A (ja) * 1982-03-25 1983-09-29 Dai Ichi Pure Chem Co Ltd 新規ペプチドアルデヒド類及びその製造法
WO1984000365A1 (en) * 1982-07-19 1984-02-02 Nat Res Dev Synthetic peptides and their preparation
CS231228B1 (en) * 1982-10-01 1984-10-15 Evzen Kasafirek Biologically effective tri and tetrapeptide alkylamide derivatives and their processing method
DE3481913D1 (de) * 1983-04-27 1990-05-17 Ici America Inc Prolin-derivate.
CA1267499A (en) * 1983-07-12 1990-04-03 Cedric H. Hassall Peptide amides and aldehydes
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
US4845242A (en) * 1987-04-28 1989-07-04 Georgia Tech Research Corporation Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
IL77748A (en) * 1985-02-04 1991-11-21 Merrell Dow Pharma Amino acid and peptide derivatives as peptidase inhibitors
CH672792A5 (no) * 1985-02-19 1989-12-29 Sandoz Ag
US5066643A (en) * 1985-02-19 1991-11-19 Sandoz Ltd. Fluorine and chlorine statine or statone containing peptides and method of use
EP0218688B1 (en) * 1985-04-19 1990-09-12 The Upjohn Company Dihalo-statine substituted renin inhibitors
ATE71934T1 (de) * 1985-06-07 1992-02-15 Ici America Inc Selektionierte difluorverbindungen.
WO1987002675A1 (en) * 1985-11-01 1987-05-07 Pfizer Inc. Difluorocyclostatine containing polypeptides
GB8613704D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro keto compounds
GB8613703D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro peptide compounds
NZ223148A (en) * 1987-01-16 1989-10-27 Merrell Dow Pharma Peptide derivatives having peptidase inhibition activity
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
JPH075634B2 (ja) * 1987-10-30 1995-01-25 日東紡績株式会社 トリペプチド類及びこれを含有する抗プラスミン剤
US4902781A (en) * 1987-11-24 1990-02-20 Taisho Pharmaceutical Co., Ltd. Novel tripetide derivatives
US5036054A (en) * 1988-02-11 1991-07-30 Warner-Lambert Company Renin inhibitors containing alpha-heteroatom amino acids
IL90872A0 (en) * 1988-07-08 1990-02-09 Smithkline Beckman Corp Retroviral protease binding peptides
YU30589A (en) * 1989-02-09 1991-10-31 Imunoloski Z Zagreb New adamantyl containing tripeptides and it's hydrochloride and process for preparing and use
GB8910547D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted ketones
US5177060A (en) * 1990-01-09 1993-01-05 Regents Of The University Of California Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues

Also Published As

Publication number Publication date
PE5195A1 (es) 1995-03-08
JPH08505143A (ja) 1996-06-04
AU697299B2 (en) 1998-10-01
AU5803994A (en) 1994-07-19
FI953106A0 (fi) 1995-06-21
CA2152267A1 (en) 1994-07-07
BR9307728A (pt) 1999-08-31
PL177914B1 (pl) 2000-01-31
CZ286126B6 (cs) 2000-01-12
FI953106A (fi) 1995-07-13
RU95113497A (ru) 1997-06-10
RU2141971C1 (ru) 1999-11-27
KR950704350A (ko) 1995-11-20
PL309638A1 (en) 1995-10-30
NO952485D0 (no) 1995-06-21
CZ164595A3 (en) 1995-12-13
WO1994014842A1 (en) 1994-07-07
HUT72977A (en) 1996-06-28
CN1095072A (zh) 1994-11-16
EP0675901A1 (en) 1995-10-11
TW402607B (en) 2000-08-21
US5760002A (en) 1998-06-02
NZ259274A (en) 1997-10-24
CN1056615C (zh) 2000-09-20
MX9400072A (es) 1994-08-31
SK82795A3 (en) 1995-12-06
IL108031A0 (en) 1994-04-12
CA2152267C (en) 2001-04-17
HU9501844D0 (en) 1995-08-28
SG54306A1 (en) 1998-11-16

Similar Documents

Publication Publication Date Title
US20070142342A1 (en) Pharmaceutical compounds
ZA86105B (en) Peptide derivatives having a nitrogenous polycyclic structure,process for the preparation thereof and pharmaceutical compositions containing them
WO1993009135A1 (en) Peptides inhibiting il-1 beta release
Rich et al. Synthesis of tentoxin and related dehydro cyclic tetrapeptides
KR870000354A (ko) N-(2-아미노 아실아미도-2-데옥시-헥소실)-아미드, -카르바메이트 및 -우레아의 제조방법
EP1084137A1 (en) Peptide inhibitors of hepatitis c virus ns3 protease
IE801342L (en) Peptides
AU599367B2 (en) Novel amino acid derivatives
CA1250398A (fr) Tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent
NO952485L (no) Antiinflammatorisk difluorpentapeptidderivat
NZ336793A (en) Method for stabilizing peptides by adding an organic acid and then lyophilizing the peptide mixture
ES2262175T3 (es) Estudios semisinteticos para dar analogos de didemnina.
Bodor et al. Soft drugs 4. 3-Spirothiazolidines of hydrocortisone and its derivatives
Nishio et al. Side reaction in peptide synthesis: Modification of tryptophan during treatment with mercury (II) acetate/2-mercaptoethanol in aqueous acetic acid
PL127100B1 (en) Method of obtaining new tripeptidamides
CA2226303A1 (en) Peptide derivatives and angiotensin iv receptor agonist
IE42784B1 (en) Tripeptides
CH647228A5 (de) Substituierte phenylessigsaeureamidverbindungen und verfahren zu ihrer herstellung.
US5145872A (en) Peptides with pharmaceutical activity
HU200985B (en) Process for production of active esthers of carbonic acid
ATE125548T1 (de) Peptide.
US3891692A (en) N-(cyclopropylalkoxycarbonyl)amino acids
AU4062693A (en) Anti-obesity drugs
KR890000769B1 (ko) 프롤린 유도체의 제법
CA1247083A (en) Peptide, process for preparation thereof and use thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application